InvestorsHub Logo
Followers 2
Posts 1257
Boards Moderated 0
Alias Born 07/16/2006

Re: None

Saturday, 09/25/2021 9:19:20 AM

Saturday, September 25, 2021 9:19:20 AM

Post# of 257
OrbiMed Advisors lowered its position in the biopharmaceutical company to 6,943,654 shares. Without citing a reason, OrbiMed sold 1,109,644 Corvus Pharmaceuticals shares on Sept. 20 at prices ranging from $6.01 to $6.09 per share. After the sale, OrbiMed now owns 16.4% of Corvus Pharmaceuticals’ tradable stock. Shares have rallied in recent days, and OrbiMed was selling at prices that were more than twice the previous week’s trading level.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRVS News